Novo Cuts Outlook Once Again, Highlighting Obesity Struggles

Novo Nordisk A/S trimmed its forecast for a fourth time this year on lagging sales of its blockbuster drugs Wegovy and ...

Ozempic Effect Is Showing Up in Obesity Data

For years, obesity rates in the US have gone in one direction: up. From the first year it was launched, Gallup’s National ...

Novo Nordisk loses further ground in obesity market

Novo Nordisk is continuing to lose ground in the obesity and diabetes markets, with the Danish drugmaker saying it expected ...

Weight loss drugs are bringing down the country's obesity rate, a survey shows

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...
Labroots

The Body's Own Ozempic

In recent years, effective obesity treatments like Ozempic and Mounjaro have changed lives. These drugs mimic the effects of ...
Healthline

Weight Loss Drugs Like Ozempic Are Lowering the U.S. Obesity Rate

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

What are some safe Ozempic alternatives for weight loss?

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Trump administration nears deals with pharmaceutical companies to offer obesity drugs for $149 a month

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...

The Ozempic effect is finally showing up in obesity data

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...
Mediafeed on MSN

Can Ozempic cause cancer?

This article was reviewed by Lynn Marie Morski, MD, JD. Does Ozempic® Cause Cancer? Key takeaways: Semaglutide — the active ...